Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy

Obstetrics and Gynecology

Volumn 77, Issue 4, 1991, Pages 595-598

  Urman, Bülent ^a   Pride, Shelia M ^a   Ho Yuen, Basil ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; TESTOSTERONE; TESTOSTERONE ENANTATE BENZILOYLHYDRAZONE;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HIRSUTISM; HUMAN; MENOPAUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; VIRILIZATION;

ADULT; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HIRSUTISM; HUMAN; MIDDLE AGE; RETROSPECTIVE STUDIES; TESTOSTERONE; VIRILISM;

EID: 0025832649     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Coope J, Thompson J, Poller L. Effects of “natural estrogen” replacement on menopausal symptoms and blood clotting. Br Med J 1975;4:139–43.
2. Bush T, Cowan L, Barrett-Connor E, et al. Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program follow-up study. JAMA 1983;249:903–6.
3. Christiansen C, Christensen M, Transbol I. Bone mass in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy. Lancet 1981;i:459–61.
4. Sherwin B, Gelfand M. Differential symptom response to parental estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985;151:153–60.
5. Tagatz G, Kopher R, Nagel T, Okagaki T. The clitoral index: A bioassay of androgenic stimulation. Obstet Gynecol 1979;54:562–4.
6. Sherwin B, Gelfand M. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes. Am J Obstet Gynecol 1984;148:552–7.
7. Barlow D, Abdalla H, Roberts A, Azzawi F, Leggate I, Hart D. Long term hormone implant therapy: Hormonal and clinical effects. Obstet Gynecol 1986;67:321–5.
8. Dow M, Hart D, Forrest C. Hormonal treatment of sexual unresponsiveness in postmenopausal women: A comparative study. Br J Obstet Gynaecol 1983;90:361–5.
9. Savvas M, Studd J, Fogelman I, Dooley M, Montgomery J, Murby B. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women. Br Med J 1988;297:331–3.
10. Horsman A, Jones M, Francis R, Nordin C. The effects of estrogen dose on postmenopausal bone loss. N Engl J Med 1983;309:1405–7.
11. Lindsay R, Hart D, Aitken J, McDonald E, Anderson J, Clark A. Long term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976;i:1038–141.
12. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman E. Estrogen replacement therapy: I. A ten year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979;53:277–81.
13. Wild R, Painter P, Coulson P, Carruth K, Ranney G. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985;61:946–51.
14. Wild R, Applebaum-Bowden D, Demers L, et al. Lipoprotein lipids in women with androgen excess: Independent associations with increased insulin and androgen. Clin Chem 1990;36:283–9.
15. Bush T, Barrett-Connor E, Cowan L, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program follow-up study. Circulation 1987;75:1102–9.
16. Sherwin BB, Gelfand MM, Schucher R, Gabor J. Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations. Am J Obstet Gynecol 1987;156:414–9.
17. Longcope C. Adrenal and gonadal androgen secretion in normal females. J Clin Endocrinol Metab 1986;15:213–28.